Literature DB >> 12208899

High titers of anti-human herpesvirus 8 antibodies in elderly males in an endemic population.

Sabine Plancoulaine1, Laurent Abel, Monique van Beveren, Antoine Gessain.   

Abstract

Human herpesvirus 8 (HHV8) is the etiologic agent of Kaposi's sarcoma (KS), a tumor occurring mainly among elderly men in its endemic and classical forms. The male-to-female ratio of KS in different endemic populations ranges from 3 : 1 to 15 : 1. We investigated the influence of age and gender on anti-HHV8 antibody titers among HHV8-seropositive subjects of an endemic population (1819 villagers with 874 men and 945 women) of African origin living in French Guiana. By using a specific immunofluorescence assay, we found that the overall HHV8 seroprevalence of antibodies against lytic antigens was 11.8%. There was no difference between seroprevalence in males (11.7%) and females (11.8%). Among the 214 HHV8-seropositive subjects, anti-HHV8 antibody titers were found to increase with age (P<.001) and were higher in males than in females (P =.003). The geometric mean of HHV8 antibody titers was 1 : 105 (95% confidence interval [CI] = 1 : 77 to 1 : 144) for males versus 1 : 62 (95% CI = 1 : 47 to 1 : 81) for females. The titers increased from 1 : 59 (95% CI = 1 : 43 to 1 : 80) in males younger than 40 years to 1 : 452 (95% CI = 1 : 244 to 1 : 839) in the oldest male group (aged 50 years and older). Such high antibody titers directed against lytic antigens in males aged 40 years and older parallel the increase of endemic KS incidence in older African men. Our results suggest that the role of gender should also be considered in evaluating the association between anti-HHV8 antibody titers in people aged 40 years and older and the risk of developing KS.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12208899     DOI: 10.1093/jnci/94.17.1333

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  8 in total

1.  Human herpesvirus 8 serological markers and viral load in patients with AIDS-associated Kaposi's sarcoma in Central African Republic.

Authors:  Renan Duprez; Eric Kassa-Kelembho; Sabine Plancoulaine; Josette Brière; Mireille Fossi; Léon Kobangue; Pierre Minsart; Michel Huerre; Antoine Gessain
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

2.  Kaposi's sarcoma in a child with Wiskott-Aldrich syndrome.

Authors:  Capucine Picard; Fethi Mellouli; Renan Duprez; Gaëlle Chédeville; Bénédicte Neven; Sylvie Fraitag; Jean Delaunay; Françoise Le Deist; Alain Fischer; Stéphane Blanche; Christine Bodemer; Antoine Gessain; Jean-Laurent Casanova; Mohamed Bejaoui
Journal:  Eur J Pediatr       Date:  2006-04-07       Impact factor: 3.183

3.  A major locus on chromosome 3p22 conferring predisposition to human herpesvirus 8 infection.

Authors:  Vincent Pedergnana; Antoine Gessain; Patricia Tortevoye; Minji Byun; Delphine Bacq-Daian; Anne Boland; Jean-Laurent Casanova; Laurent Abel; Sabine Plancoulaine
Journal:  Eur J Hum Genet       Date:  2012-01-18       Impact factor: 4.246

Review 4.  Is human herpesvirus 8 infection more common in men than in women? Systematic review and meta-analysis.

Authors:  Lorin Begré; Eliane Rohner; Sam M Mbulaiteye; Matthias Egger; Julia Bohlius
Journal:  Int J Cancer       Date:  2016-04-26       Impact factor: 7.396

5.  Novel human herpesvirus 8 subtype D strains in Vanuatu, Melanesia.

Authors:  Olivier Cassar; Philippe V Afonso; Sylviane Bassot; Sabine Plancoulaine; Renan Duprez; Corinne Capuano; Myriam Abel; Paul M V Martin; Antoine Gessain
Journal:  Emerg Infect Dis       Date:  2007-11       Impact factor: 6.883

6.  Risk factors for high anti-HHV-8 antibody titers (> or =1:51,200) in black, HIV-1 negative South African cancer patients: a case control study.

Authors:  Janet M Wojcicki; Rob Newton; Margaret I Urban; Lara Stein; Martin Hale; Moosa Patel; Paul Ruff; Ranjan Sur; Dimitra Bourboulia; Freddy Sitas
Journal:  BMC Infect Dis       Date:  2003-09-12       Impact factor: 3.090

7.  Infection with Kaposi's sarcoma-associated herpesvirus (KSHV) and human immunodeficiency virus (HIV) in relation to the risk and clinical presentation of Kaposi's sarcoma in Uganda.

Authors:  R Newton; J Ziegler; D Bourboulia; D Casabonne; V Beral; E Mbidde; L Carpenter; D M Parkin; H Wabinga; S Mbulaiteye; H Jaffe; R Weiss; C Boshoff
Journal:  Br J Cancer       Date:  2003-08-04       Impact factor: 7.640

8.  Epidemiology and genetic variability of HHV-8/KSHV in Pygmy and Bantu populations in Cameroon.

Authors:  Edouard Betsem; Olivier Cassar; Philippe V Afonso; Arnaud Fontanet; Alain Froment; Antoine Gessain
Journal:  PLoS Negl Trop Dis       Date:  2014-05-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.